---
title: "Merck KGaA agrees to buy Bio-Techne for USD 73 a share in cash"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291315408.md"
description: "Merck KGaA has agreed to acquire Bio-Techne in an all-cash deal, offering USD 73 per share. The transaction is projected to close in late 2026 or early 2027, pending customary closing conditions. Upon completion, Bio-Techne shares are expected to be delisted from the Nasdaq."
datetime: "2026-06-30T16:54:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291315408.md)
  - [en](https://longbridge.com/en/news/291315408.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291315408.md)
generator: "portal-rs"
---

# Merck KGaA agrees to buy Bio-Techne for USD 73 a share in cash

-   Merck KGaA agreed to acquire Bio-Techne in an all-cash deal valuing each share at USD 73. \* The transaction is expected to close in late 2026 or early 2027, subject to customary closing conditions. \* Bio-Techne shares are expected to be delisted from the Nasdaq upon completion. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio-Techne Corporation published the original content used to generate this news brief on June 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [TECH.US](https://longbridge.com/en/quote/TECH.US.md)
- [MRK.DE](https://longbridge.com/en/quote/MRK.DE.md)
- [MKKGY.US](https://longbridge.com/en/quote/MKKGY.US.md)

## Related News & Research

- [TECH Stock Alert: Halper Sadeh LLC is Investigating Whether Bio-Techne Corporation is Obtaining a Fair Price for its Shareholders](https://longbridge.com/en/news/296677873.md)
- [TECH: Revenue up 12% but margins and profitability fell; cost actions and rights issue underway](https://longbridge.com/en/news/296451054.md)
- [Skye Bio amends 8-K to set Aug. 24 effective date for reverse stock split](https://longbridge.com/en/news/296471274.md)
- [Adicet Bio, Inc. (NASDAQ:ACET) Given Consensus Rating of "Moderate Buy" by Analysts](https://longbridge.com/en/news/296801308.md)
- [Bio Engineering Capital-created AI Dock raises JPY 260 million in seed round](https://longbridge.com/en/news/296442437.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**